Custom immune cells for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a special type of immune cell therapy for people with advanced gastric cancer. The treatment uses your own immune cells that are specially trained to find and attack cancer cells. It may help when standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to have advanced gastric cancer that has not responded to standard treatments, and no effective treatment is currently available.
- You must have at least one tumor that can be measured on a scan.
- Your life expectancy should be at least 5 months.
- You should be reasonably active (able to do light activity or be up and around more than half the day).
- Your blood counts and liver/kidney function need to be within certain ranges.
- You must not have serious infections like hepatitis B or C, HIV, syphilis, or tuberculosis.
- You must not have cancer that has spread to the brain or spinal fluid.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving immunotherapy before surgery can help shrink advanced stomach cancer and improve outcomes. Immunotherapy uses your body's own immune system to fight cancer cells.
This early-phase trial tests a new type of immune cell therapy (TCRx T cells) for advanced stomach cancer that has not responded to standard chemotherapy. The goal is to see if these specially engineered cells can help your body fight the cancer.
This trial tests a new type of cell therapy that uses your own immune cells, modified to target proteins found on some stomach cancer cells. It is for people with advanced stomach cancer that has not responded to standard treatments.
This trial is testing a new combination treatment for advanced or metastatic stomach cancer (that is MSS/pMMR and HER2-negative) that has not been treated before. The treatment combines a short course of radiation (targeted to lymph nodes) with first-line therapy and a PD-1 inhibitor (a type of immunotherapy) to see if it can help control the cancer and improve outcomes.
This trial studies an experimental cell therapy called NK510 for people with advanced stomach or colorectal cancer that has not responded to standard treatments. The therapy uses natural killer cells, a type of immune cell, to attack the cancer. It may help slow or stop the cancer's growth.
This trial tests a new type of cell therapy using your own immune cells (T-cells) that are specially trained to attack your cancer. It is for people with advanced gastrointestinal cancers like esophageal, stomach, or colon cancer that have not responded to other treatments.
Hear when a new Advanced Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.